Product Information
NICARDIPINE 30 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $3.9440 per EA under NDC 69238269201. Its NADAC has been published 76 times since Feb 5, 2025.
FDA first approved this application on Apr 10, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238269201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/23/2025
Active Ingredients
NICARDIPINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA218202FDA Approved
4/10/2024
TE Code
AB
On Market Since
10/3/2024
Pharmacological Classes
Price Statistics
The NADAC for NICARDIPINE 30 MG CAPSULE has been published 76 times since Feb 5, 2025, and over the history we have for it it has risen 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.9440 per EA |
|---|---|
| All-time high | $3.9440 (Jul 15, 2026) |
| All-time low | $3.3006 (Feb 5, 2025) |
| 52-week high | $3.9440 |
| 52-week low | $3.9440 |
| Median price | $3.9440 |
| Average price | $3.8520 |
| Largest weekly change | +6.0% (Apr 23, 2025) |
| Weeks tracked | 76 |
| Tracking since | Feb 5, 2025 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
+19.5%
Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Nicardipine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nicardipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NICARDIPINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NICARDIPINE 30 MG CAPSULE, manufactured by Amneal Pharmaceuticals NY LLC, is $3.9440 per EA (NDC 69238269201), effective Jul 15, 2026.
How has the price of NICARDIPINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NICARDIPINE 30 MG CAPSULE has risen 19.5%. It has been tracked across 76 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for NICARDIPINE 30 MG CAPSULE?
Since Feb 5, 2025, the NADAC for NICARDIPINE 30 MG CAPSULE has ranged from a low of $3.3006 (Feb 5, 2025) to a high of $3.9440 (Jul 15, 2026), with a median of $3.9440 per EA.
Are there cheaper alternatives to NICARDIPINE 30 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of NICARDIPINE 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NICARDIPINE 30 MG CAPSULE?
NICARDIPINE 30 MG CAPSULE (NDC 69238269201) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.